Channel Therapeutics shows a troubling financial picture with a stark decrease in performance metrics, significant insider ownership, and no revenue or earnings. The massive insider ownership suggests potential conflicts of interest or lack of external confidence, while the financial instability indicated by negative equity and no sales revenue highlights severe operational challenges.